Calumet cut to Sell at UBS on regulatory uncertainty, likely negative revisions
Calumet Specialty Products (NASDAQ:CLMT) -5.8% in Tuesday's trading as UBS downgrades shares to Sell from Neutral with a $15 price target, slashed from $20.50, citing uncertainty over the Department ...